Follow
Myron Schwartz
Myron Schwartz
Verified email at mountsinai.org
Title
Cited by
Cited by
Year
Sorafenib in advanced hepatocellular carcinoma
JM Llovet, S Ricci, V Mazzaferro, P Hilgard, E Gane, JF Blanc, ...
New England journal of medicine 359 (4), 378-390, 2008
147892008
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
V Mazzaferro, JM Llovet, R Miceli, S Bhoori, M Schiavo, L Mariani, ...
The lancet oncology 10 (1), 35-43, 2009
21372009
Design and endpoints of clinical trials in hepatocellular carcinoma
JM Llovet, AM Di Bisceglie, J Bruix, BS Kramer, R Lencioni, AX Zhu, ...
Journal of the National Cancer Institute 100 (10), 698-711, 2008
20332008
Gene expression in fixed tissues and outcome in hepatocellular carcinoma
Y Hoshida, A Villanueva, M Kobayashi, J Peix, DY Chiang, A Camargo, ...
New England Journal of Medicine 359 (19), 1995-2004, 2008
13272008
Resection and liver transplantation for hepatocellular carcinoma
JM Llovet, M Schwartz, V Mazzaferro
Seminars in liver disease 25 (02), 181-200, 2005
11112005
Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
JW Park, M Chen, M Colombo, LR Roberts, M Schwartz, PJ Chen, ...
Liver International 35 (9), 2155-2166, 2015
10752015
α-fetoprotein, des-γ carboxyprothrombin, and lectin-bound α-fetoprotein in early hepatocellular carcinoma
JA Marrero, Z Feng, Y Wang, MH Nguyen, AS Befeler, LR Roberts, ...
Gastroenterology 137 (1), 110-118, 2009
8422009
Pivotal role of mTOR signaling in hepatocellular carcinoma
A Villanueva, DY Chiang, P Newell, J Peix, S Thung, C Alsinet, V Tovar, ...
Gastroenterology 135 (6), 1972-1983. e11, 2008
8222008
Identification of an immune-specific class of hepatocellular carcinoma, based on molecular features
D Sia, Y Jiao, I Martinez-Quetglas, O Kuchuk, C Villacorta-Martin, ...
Gastroenterology 153 (3), 812-826, 2017
7452017
Focal gains of VEGFA and molecular classification of hepatocellular carcinoma
DY Chiang, A Villanueva, Y Hoshida, J Peix, P Newell, B Minguez, ...
Cancer research 68 (16), 6779-6788, 2008
7302008
Genome‐wide molecular profiles of HCV‐induced dysplasia and hepatocellular carcinoma
E Wurmbach, Y Chen, G Khitrov, W Zhang, S Roayaie, M Schwartz, I Fiel, ...
Hepatology 45 (4), 938-947, 2007
7272007
Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis
P Tabrizian, G Jibara, B Shrager, M Schwartz, S Roayaie
Annals of surgery 261 (5), 947-955, 2015
7022015
A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma
S Roayaie, IN Blume, SN Thung, M Guido, MI Fiel, S Hiotis, DM Labow, ...
Gastroenterology 137 (3), 850-855, 2009
6492009
The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies
J Ozao-Choy, G Ma, J Kao, GX Wang, M Meseck, M Sung, M Schwartz, ...
Cancer research 69 (6), 2514-2522, 2009
6052009
Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes
D Sia, Y Hoshida, A Villanueva, S Roayaie, J Ferrer, B Tabak, J Peix, ...
Gastroenterology 144 (4), 829-840, 2013
5582013
Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters
S Roayaie, JS Frischer, SH Emre, TM Fishbein, PA Sheiner, M Sung, ...
Annals of surgery 235 (4), 533-539, 2002
5042002
Unsuspected osteomyelitis in diabetic foot ulcers: diagnosis and monitoring by leukocyte scanning with indium in 111 oxyquinoline
LG Newman, J Waller, CJ Palestro, M Schwartz, MJ Klein, G Hermann, ...
Jama 266 (9), 1246-1251, 1991
5031991
Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis
S Roayaie, JD Schwartz, MW Sung, SH Emre, CM Miller, GE Gondolesi, ...
Liver Transplantation 10 (4), 534-540, 2004
4952004
A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis
JM Llovet, Y Chen, E Wurmbach, S Roayaie, MI Fiel, M Schwartz, ...
Gastroenterology 131 (6), 1758-1767, 2006
4632006
Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma
A Villanueva, Y Hoshida, C Battiston, V Tovar, D Sia, C Alsinet, ...
Gastroenterology 140 (5), 1501-1512. e2, 2011
4472011
The system can't perform the operation now. Try again later.
Articles 1–20